You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Advanced Battery Manufacturing Technologies
SBC: K2 ENERGY SOLUTIONS, INC. Topic: DLA142001K2 Energy Solutions, a manufacturer of lithium ion batteries headquartered in Henderson, NV, will develop a cell manufacturing process that eliminates the use of VOCs. The elimination of VOCs will result in substantial reductions in cell raw materials costs as well as substantial reductions in facility construction and operational costs.
SBIR Phase I 2014 Department of DefenseDefense Logistics Agency -
Point-of-care immunoassay for early diagnosis of pertussis
SBC: DXDISCOVERY INC Topic: NIAIDDESCRIPTION provided by applicant Pertussis is a serious and potentially life threatening respiratory disease caused by the bacterium Bordetella pertussis Worldwide million people become ill with pertussis each year and of these patients die Despite high vaccine coverage in the United States there were still over pertussis cases reported in the U S in Rapid diagn ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Advanced Technologies for Discrete-Parts Manufacturing
SBC: MANUFACTURING LABORATORIES, INC. Topic: DLA08001Significant advances have been made in machining technology, most notably machining centers capable of spindle speeds and feedrates that are an order of magnitude higher than conventional. However, the use of this new technology requires much more technical expertise, and experience and intuition are no longer sufficient. Specifically, machine tool productivity can be greatly enhanced if informati ...
SBIR Phase I 2009 Department of DefenseDefense Logistics Agency -
Microscopic Traffic Flow Simulation Models- An Open Source Approach
SBC: NEW GLOBAL SYSTEMS FOR INTELLIGENT TRANSPORTATION MANAGEMENT CORPORATION Topic: 081FH5In the Open-source microscopic traffic simulation models project, a component based software framework is proposed to re-engineer CORISM data struture and CORISM interface. Under the architecture combing the innovative framework and the legacy CORISM, prototype of the open source traffic flow simulation models will be developed and demonstrated in the Phase I. In addition, areas identified by th ...
SBIR Phase I 2008 Department of Transportation -
Thermally Targeted Delivery of Therapeutic Peptides
SBC: Thermally Targeted Therapeutics, Incorporated Topic: N/ADESCRIPTION (provided by applicant): Current treatment of solid tumors is limited by normal tissue tolerance, inherent tumor resistance to radiation or chemotherapy, and toxicity from systemic administration of antineoplastic agents. The result is a narrow therapeutic index for most current chemotherapeutic agents. Our long term goal is to overcome these limitations by developing a targeted therap ...
SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health -
Public Rights-of-Way Assessment Instrumentation to Determine Accessibility
SBC: BENEFICIAL DESIGNS INC Topic: N/ACities must perform detailed assessments of sidewalks and streets, including curb ramps, pedestrian signals, crosswalks, street furniture, and other components to determine compliance with the Public Rights-of-Way Accessibility Guidelines. However, current assessment methods are inadequate or unreasonable due to time and resources required. The objectives of this project are to: 1) develop elect ...
SBIR Phase I 2008 Department of Transportation -
A NOVEL TARGETED DELIVERY SYSTEM FOR CANCER TREATMENT AND DIAGNOSIS
SBC: ENDURX PHARMACEUTICALS INC Topic: NCIDESCRIPTION (provided by applicant): Glioblastoma multiforme (GBM) or glioblastoma, is the most common and aggressive malignant primary brain tumor in humans. An effective treatment that increases patient survival would represent a significant advance inthe field, and provide a desperately needed new therapy for this deadly disease. EnduRx is focused on the development of new, targeted systems f ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health